KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Net Cash Flow (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Net Cash Flow data on record, last reported at $2.8 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 61.39% year-over-year to $2.8 million; the TTM value through Dec 2025 reached -$8.4 million, up 86.33%, while the annual FY2025 figure was -$8.4 million, 86.33% up from the prior year.
  • Net Cash Flow reached $2.8 million in Q4 2025 per CRL's latest filing, down from $27.5 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $227.0 million in Q1 2021 and bottomed at -$249.6 million in Q2 2021.
  • Average Net Cash Flow over 5 years is -$3.5 million, with a median of $1.4 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: skyrocketed 311.29% in 2021, then tumbled 314771.43% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $19.6 million in 2021, then surged by 54.06% to $30.2 million in 2022, then surged by 251.64% to $106.1 million in 2023, then tumbled by 93.05% to $7.4 million in 2024, then plummeted by 61.39% to $2.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $2.8 million in Q4 2025, $27.5 million in Q3 2025, and -$59.7 million in Q2 2025.